Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$1.6 - $2.37 $42,667 - $63,200
-26,667 Reduced 70.72%
11,040 $20,000
Q3 2022

Nov 14, 2022

SELL
$2.04 - $4.32 $80,755 - $171,011
-39,586 Reduced 51.22%
37,707 $79,000
Q1 2022

May 16, 2022

BUY
$3.92 - $7.48 $101,183 - $193,073
25,812 Added 50.14%
77,293 $345,000
Q4 2021

Feb 14, 2022

BUY
$6.7 - $11.38 $183,774 - $312,142
27,429 Added 114.04%
51,481 $371,000
Q3 2021

Nov 15, 2021

BUY
$10.11 - $17.56 $243,165 - $422,353
24,052 New
24,052 $259,000

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $39.8M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.